Home/Filings/4/0001227025-22-000129
4//SEC Filing

Jenks Timothy Storrs 4

Accession 0001227025-22-000129

CIK 0001227025other

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 3:36 PM ET

Size

8.4 KB

Accession

0001227025-22-000129

Insider Transaction Report

Form 4
Period: 2022-07-26
Jenks Timothy Storrs
DirectorPresident, CEO and Chairman
Transactions
  • Sale

    Common Stock

    2022-07-26$15.78/sh8,500$134,130456,784 total
Holdings
  • Common Stock

    (indirect: By Trust)
    3,076
  • Common Stock

    (indirect: By Trust)
    3,200
  • Common Stock

    (indirect: By Trust)
    32,465
  • Common Stock

    (indirect: By Trust)
    32,465
  • Common Stock

    (indirect: By Trust)
    3,798
Footnotes (4)
  • [F1]Sale pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F2]Represents shares held by Timothy S. Jenks in a Charitable Lead Annuity Trust dated April 28, 2022.
  • [F3]Represents shares held by Atsuko K. Jenks in a Charitable Lead Annuity Trust dated April 28, 2022.
  • [F4]Represents shares held by Timothy S. Jenks and Atsuko K. Jenks Declaration of Trust dated January 7, 1996.

Issuer

NEOPHOTONICS CORP

CIK 0001227025

Entity typeother

Related Parties

1
  • filerCIK 0001488795

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 3:36 PM ET
Size
8.4 KB